Drug-resistant tuberculosis in Afghanistan: We must continue to put people at the center of treatment
February 22, 2022In recent years, Doctors Without Borders/Médecins Sans Frontières (MSF) has been able to improve patients' experiences of care for drug-resistant tuberculosis (DR-TB), but the changing political situation threatens to derail this progress, writes Anita Mesic, MSF tuberculosis (TB), HIV, and hepatitis adviser. This...
Read more
Tuberculosis: Policies should ‘help facilitate access to life saving treatment not create barriers.’
August 20, 2020Stobdan Kalon is a medical doctor working with Medecins Sans Frontieres/Doctors Without Borders (MSF). His experience spans from managing infectious diseases, interventions in Drug Resistant-Tuberculosis (DR-TB), hepatitis and HIV. As a doctor, I am elated that the World Health Organization...
Read more
